RecruitingNCT05882773

Asian Myeloproliferative Neoplasm (MPN) Registry

Asian Myeloproliferative Neoplasm (MPN) Registry - An Asian Myeloid Working Group (AMWG) Project.

Sponsor

The University of Hong Kong

Enrollment

1,000 participants

Start Date

May 1, 2023

Study Type

OBSERVATIONAL

Conditions

This is a multinational, multicenter, prospective and retrospective, observational, cohort study of patients with myeloproliferative neoplasm.

Min Age: 18 Years

Age ≥ 18 years old at the time of diagnosis of MPN.
Subject was diagnosed with one of the following disorders according to the 2017 WHO classification (for patients diagnosed before 2017, the bone marrow reports will be re-evaluated according to the 2017 WHO classification):
Polycythaemia vera
Essential thrombocythemia
Primary myelofibrosis, pre-fibrotic/early stage
Primary myelofibrosis, overt fibrotic stage
Post-polycythaemia vera myelofibrosis
Post-essential thrombocythaemia myelofibrosis
MPN-unclassifiable
All subjects need to provide informed consent.

A subject will not be eligible if he/she meets any of the following criteria:
\. Subject was diagnosed with myelodysplastic syndrome, myelodysplastic syndrome/myeloproliferative neoplasm, or chronic myeloid leukaemia BCR-ABL1 positive, under the 2017 WHO classification

Interested in this trial?

Get notified about updates and connect with the research team.

Department of Medicine, Queen Mary Hospital

Hong Kong, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

NCT05882773